Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis

作者: Zhiyong Ren , Yufeng Li , Tiansheng Shen , Omar Hameed , Gene P. Siegal

DOI: 10.1016/J.PRP.2015.11.003

关键词:

摘要: Prognostic factors are well established in early-stage breast cancer (BC), but less well-defined advanced disease. We analyzed 323 BC patients who had distant relapse during follow-up from 1997 to 2010 determine the significant clinicopathologic predicting survival outcomes. By univariate analysis, race, tumor grade, estrogen and progesterone receptors (ER/PR) HER2 status were significantly associated with overall (OS) post-metastasis (PMS). Applying a Cox regression model revealed that all these remained for PMS, while grade independent OS. Tumor was only factor metastasis-free by multivariate analyses. Our findings demonstrated being Caucasian, hormonal receptor positive (HR+) (HER2+) decreased hazard of death HR+/HER2+ tumors superior outcomes those HR+/HER2- Further, PR held prognostic value over ER, thus reflecting biologic mechanism importance functional ER pathway heterogeneity response endocrine therapy. These observations indicate patients' genetic makeup intrinsic nature principally govern progression prognosticate long-term

参考文章(48)
Jenny Chang, Gary M. Clark, D. Craig Allred, Syed Mohsin, Gary Chamness, Richard M. Elledge, Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. ,vol. 97, pp. 545- 553 ,(2003) , 10.1002/CNCR.11083
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049
E. Planchat, X. Durando, C. Abrial, E. Thivat, M. A. Mouret-Reynier, J. P. Ferrière, C. Pomel, F. Kwiatkowski, P. Chollet, J. M. Nabholtz, Prognostic Value of Initial Tumor Parameters After Metastatic Relapse Cancer Investigation. ,vol. 29, pp. 635- 643 ,(2011) , 10.3109/07357907.2011.621911
Jose M. Pacheco, Feng Gao, Caroline Bumb, Matthew J. Ellis, Cynthia X. Ma, Racial differences in outcomes of triple-negative breast cancer Breast Cancer Research and Treatment. ,vol. 138, pp. 281- 289 ,(2013) , 10.1007/S10549-012-2397-6
Hans-Olov Adami, Birgitta Malker, Lars Holmberg, Ingemar Persson, Betty Stone, The relation between survival and age at diagnosis in breast cancer. The New England Journal of Medicine. ,vol. 315, pp. 559- 563 ,(1986) , 10.1056/NEJM198608283150906
Amelia Insa, Ana Lluch, Felipe Prosper, Isabel Marugan, Angel Martinez‐Agullo, Javier Garcia‐Conde, Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients Breast Cancer Research and Treatment. ,vol. 56, pp. 67- 78 ,(1999) , 10.1023/A:1006285726561
Zhiyong Ren, Yufeng Li, Omar Hameed, Gene P. Siegal, Shi Wei, Prognostic factors in patients with metastatic breast cancer at the time of diagnosis Pathology Research and Practice. ,vol. 210, pp. 301- 306 ,(2014) , 10.1016/J.PRP.2014.01.008